Send to:

Choose Destination
See comment in PubMed Commons below
J Korean Surg Soc. 2012 May;82(5):271-80. doi: 10.4174/jkss.2012.82.5.271. Epub 2012 Apr 26.

Gene expression profiling of papillary thyroid carcinomas in Korean patients by oligonucleotide microarrays.

Author information

  • 1Center for Thyroid Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.



The incidence of papillary thyroid carcinomas (PTCs) is rapidly increasing in Korea. Analyzing the gene expression profiling (GEP) of PTCs will facilitate the advent of new methods in diagnosis, prognostication, and treatment. We performed this study to find the GEP of Korean PTCs.


We performed oligonucleotide microarray analysis with 19 PTCs and 7 normal thyroid glands. Differentially expressed genes were selected using a t-test (|fold| >3) and adjusted Benjamini-Hochberg false discovery rate P-value < 0.01. Quantitative reverse transcription-polymerase chain reaction (QRT-PCR) was used to validate microarray data. A classification model was developed by support vector machine (SVM) algorithm to diagnose PTCs based on molecular signatures.


We identified 79 differentially expressed genes (70 up-regulated and 9 down-regulated) according to the criteria. QRT-PCR for five genes (CDH3, NGEF, PROS1, TGFA, MET) was confirmatory of the microarray data. Hierarchical cluster analysis and a classification model by the SVM algorithm accurately differentiated PTCs from normal thyroid gland based on GEP.


A disease classification model showed excellent accuracy in diagnosing PTCs, thus showing the possibility of molecular diagnosis in the future. This GEP could serve as baseline data for further investigation in the management of PTCs based on molecular signatures.


Gene expression profiling; Microarray; Papillary; Thyroid neoplasms

Free PMC Article
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for The Korean Surgical Society Icon for PubMed Central
    Loading ...
    Write to the Help Desk